Frequency of Ventricular Arrhythmias and Other Rhythm Abnormalities in Children and Young Adults With the Marfan Syndrome

• Published in: The American journal of cardiology 2018-10, Vol.122 (8), p.1429-1436
• Main Authors: Mah, Douglas Y., Sleeper, Lynn A., Crosson, Jane E., Czosek, Richard J., Love, Barry A., McCrindle, Brian W., Muiño-Mosquera, Laura, Olson, Aaron K., Pilcher, Thomas A., Tierney, Elif Seda Selamet, Shah, Maully J., Wechsler, Stephanie B., Young, Luciana T., Lacro, Ronald V.
• Format: Article
• Language: English
• Subjects: Abnormalities; Adolescent; Adrenergic beta-Antagonists - therapeutic use; Adult; Adults; Age; Angiotensin II Type 1 Receptor Blockers - therapeutic use; Aorta; Aortic dissection; Arrhythmia; Arrhythmias, Cardiac - diagnostic imaging; Arrhythmias, Cardiac - drug therapy; Arrhythmias, Cardiac - etiology; Arrhythmias, Cardiac - physiopathology; Atenolol; Atenolol - therapeutic use; Cardiac arrhythmia; Child; Child, Preschool; Children; Dissection; Echocardiography; Electrocardiography, Ambulatory; Female; Heart rate; Humans; Infant; Losartan - therapeutic use; Male; Marfan syndrome; Marfan Syndrome - complications; Marfan Syndrome - physiopathology; Monitoring; Mortality; Mutation; Patients; Pediatrics; Retrospective Studies; Surgery; Tachycardia; Ventricle; Young adults
• ISSN: 0002-9149; 1879-1913
• DOI: 10.1016/j.amjcard.2018.07.006

Patients with the Marfan syndrome (MFS) are at risk for sudden death. The contribution of arrhythmias is unclear. This study examines the prevalence of arrhythmias in children with the MFS and their relation to clinical and/or echocardiographic factors. Data from the Pediatric Heart Network randomized trial of atenolol versus losartan in MFS were analyzed (6 months to 25 years old, aortic root diameter z-score > 3.0, no previous aortic surgery and/or dissection). Baseline 24-hour ambulatory electrocardiographic monitoring was performed. Significant ventricular ectopy (VE) and supraventricular ectopy (SVE) were defined as ≥10 VE or SVE/hour, or the presence of high-grade ectopy. Three-year composite clinical outcome of death, aortic dissection, or aortic root replacement was analyzed. There were 274 analyzable monitors on unique patients from 11 centers. Twenty subjects (7%) had significant VE, 13 (5%) significant SVE; of these, 2 (1%) had both. None had sustained ventricular or supraventricular tachycardia. VE was independently associated with increasing number of major Ghent criteria (odds ratio [OR] = 2.13/each additional criterion, p = 0.03) and greater left ventricular end-diastolic dimension z-score (OR = 1.47/each 1 unit increase in z-score, p = 0.01). SVE was independently associated with greater aortic sinotubular junction diameter z-score (OR = 1.56/each 1 unit increase in z-score, p = 0.03). The composite clinical outcome (14 events) was not related to VE or SVE (p ≥ 0.3), but was independently related to heart rate variability (higher triangular index). In conclusion, in this cohort, VE and SVE were rare. VE was related to larger BSA-adjusted left ventricular size. Routine ambulatory electrocardiographic monitoring may be useful for risk stratification in select MFS patients.